Hostname: page-component-7b9c58cd5d-sk4tg Total loading time: 0 Render date: 2025-03-14T19:38:48.480Z Has data issue: false hasContentIssue false
  • English
  • Français

Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia

Published online by Cambridge University Press:  22 September 2010

S. M. Eack ,
M. F. Pogue-Geile ,
D. P. Greenwald ,
S. S. Hogarty  and
M. S. Keshavan
S. M. Eack*
Affiliation:
School of Social Work, University of Pittsburgh, Pittsburgh, PA, USA Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
M. F. Pogue-Geile
Affiliation:
Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA
D. P. Greenwald
Affiliation:
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
S. S. Hogarty
Affiliation:
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
M. S. Keshavan
Affiliation:
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
*
*Address for correspondence: S. M. Eack, Ph.D., University of Pittsburgh School of Social Work, 2117 Cathedral of Learning, Pittsburgh, PA 15260, USA. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Cognitive rehabilitation has emerged as an effective treatment for addressing cognitive impairments and functional disability in schizophrenia; however, the degree to which changes in various social and non-social cognitive processes translate into improved functioning during treatment remains unclear. This research sought to identify the neurocognitive and social-cognitive mechanisms of functional improvement during a 2-year trial of cognitive enhancement therapy (CET) for early-course schizophrenia.

Method

Patients in the early course of schizophrenia were randomly assigned to CET (n=31) or an enriched supportive therapy control (n=27) and treated for up to 2 years. A comprehensive neurocognitive assessment battery and the Mayer–Salovey–Caruso Emotional Intelligence Test (MSCEIT) were completed annually, along with measures of functioning. Mediator analyses using mixed-effects growth models were conducted to examine the effects of neurocognitive and social-cognitive improvement on functional change.

Results

Improvements over 2 years in neurocognition and the emotion management branch of the MSCEIT were found to be significantly related to improved functional outcome in early-course schizophrenia patients. Neurocognitive improvement, primarily in executive functioning, and social-cognitive change in emotion management also mediated the robust effects of CET on functioning.

Conclusions

Improvements in neurocognition and social cognition that result from cognitive rehabilitation are both significant mediators of functional improvement in early-course schizophrenia. Cognitive rehabilitation programs for schizophrenia may need to target deficits in both social and non-social cognition to achieve an optimal functional response.

Keywords

Cognitive rehabilitationcognitive remediationpsychosocial treatmentsocial cognition
Type
Original Articles
Information
Psychological Medicine , Volume 41 , Issue 6 , June 2011 , pp. 1253 - 1261
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baron, RM, Kenny, DA (1986). The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51, 1173–1182.CrossRefGoogle ScholarPubMed
Brekke, JS, Hoe, M, Green, MF (2009). Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia. Psychological Medicine 39, 1637–1647.CrossRefGoogle ScholarPubMed
Brekke, JS, Hoe, M, Long, J, Green, MF (2007). How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophrenia Bulletin 33, 1247–1256.CrossRefGoogle ScholarPubMed
Buchanan, RW, Heinrichs, DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335–350.CrossRefGoogle Scholar
Campbell, DT, Stanley, JC (1963). Experimental and Quasi-Experimental Designs for Research. Houghton Mifflin: Boston, MA.Google Scholar
Couture, SM, Penn, DL, Roberts, DL (2006). The functional significance of social cognition in schizophrenia: a review. Schizophrenia Bulletin 32 (Suppl. 1), S44–S63.CrossRefGoogle ScholarPubMed
Delis, DC, Kramer, JH, Kaplan, E, Ober, BA (1987). California Verbal Learning Test Manual. Psychological Corp.: San Antonio, TX.Google Scholar
Dempster, AP, Laird, NM, Rubin, DB (1977). Maximum likelihood from incomplete data using the EM algorithm. Journal of the Royal Statistical Society. Series B (Methodological) 39, 1–38.CrossRefGoogle Scholar
Department of Health and Human Services (1986). Disability Evaluation Under Social Security. Department of Health and Human Services: Washington, DC.Google Scholar
Eack, SM, Greeno, CG, Pogue-Geile, MF, Newhill, CE, Hogarty, GE, Keshavan, MS (2010). Assessing social-cognitive deficits in schizophrenia with the Mayer–Salovey–Caruso Emotional Intelligence Test. Schizophrenia Bulletin 36, 370–380.CrossRefGoogle ScholarPubMed
Eack, SM, Greenwald, DP, Hogarty, SS, Cooley, SJ, DiBarry, AL, Montrose, DM, Keshavan, MS (2009). Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatric Services 60, 1468–1476.CrossRefGoogle ScholarPubMed
Eack, SM, Hogarty, GE, Greenwald, DP, Hogarty, SS, Keshavan, MS (2007). Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophrenia Research 89, 308–311.CrossRefGoogle ScholarPubMed
Eack, SM, Hogarty, GE, Greenwald, DP, Hogarty, SS, Keshavan, MS (in press). Effects of cognitive enhancement therapy on employment outcomes in early schizophrenia: results from a two-year randomized trial. Research on Social Work Practice.Google Scholar
Endicott, J, Spitzer, RL, Fleiss, JL, Cohen, J (1976). The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766–771.CrossRefGoogle Scholar
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. Biometrics Research, New York State Psychiatric Institute: New York.Google Scholar
Green, MF, Kern, RS, Braff, DL, Mintz, J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff? Schizophrenia Bulletin 26, 119–136.CrossRefGoogle ScholarPubMed
Green, MF, Nuechterlein, KH (1999). Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin 25, 309–319.CrossRefGoogle ScholarPubMed
Green, MF, Nuechterlein, KH, Gold, JM, Barch, DM, Cohen, J, Essock, S, Fenton, WS, Frese, F, Goldberg, TE, Heaton, RK, Keefe, RS, Kern, RS, Kraemer, H, Stover, E, Weinberger, DR, Zalcman, S, Marder, SR (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 56, 301–307.CrossRefGoogle ScholarPubMed
Heaton, RK, Chelune, GJ, Talley, JL, Kay, GG, Curtiss, G (1993). Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resources Inc.: Odessa, FL.Google Scholar
Heinrichs, RW, Zakzanis, KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426–445.CrossRefGoogle ScholarPubMed
Hogarty, GE (2002). Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment. Guilford: New York.Google Scholar
Hogarty, GE, Flesher, S (1992). Cognitive remediation in schizophrenia: proceed … with caution! Schizophrenia Bulletin 18, 51–57.CrossRefGoogle ScholarPubMed
Hogarty, GE, Flesher, S, Ulrich, R, Carter, M, Greenwald, D, Pogue-Geile, M, Kechavan, M, Cooley, S, DiBarry, AL, Garrett, A, Parepally, H, Zoretich, R (2004). Cognitive enhancement therapy for schizophrenia. Effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry 61, 866–876.CrossRefGoogle ScholarPubMed
Hogarty, GE, Goldberg, SC, Schooler, NR, the Collaborative Study Group (1974). Drug and sociotherapy in the aftercare of schizophrenic patients: III. Adjustment of nonrelapsed patients. Archives of General Psychiatry 31, 609–618.CrossRefGoogle ScholarPubMed
Hogarty, GE, Greenwald, DP (2006). Cognitive enhancement therapy (http://www.cognitiveenhancementtherapy.com). Accessed 1 September 2010.Google Scholar
Hogarty, GE, Greenwald, DP, Eack, SM (2006). Durability and mechanism of effects of cognitive enhancement therapy. Psychiatric Services 57, 1751–1757.CrossRefGoogle ScholarPubMed
Keefe, RSE, Bilder, RM, Davis, SM, Harvey, PD, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Capuano, G, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Davis, CE, Hsiao, JK, Lieberman, JA; CATIE Investigators; Neurocognitive Working Group (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 64, 633–647.CrossRefGoogle ScholarPubMed
Kraemer, HC, Wilson, G, Fairburn, CG, Agras, W (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59, 877–884.CrossRefGoogle ScholarPubMed
MacKinnon, DP, Lockwood, CM, Hoffman, JM, West, SG, Sheets, V (2002). A comparison of methods to test mediation and other intervening variable effects. Psychological Methods 7, 83–104.CrossRefGoogle ScholarPubMed
Mayer, JD, Salovey, P, Caruso, DR, Sitarenios, G (2003). Measuring emotional intelligence with the MSCEIT V2.0. Emotion 3, 97–105.CrossRefGoogle ScholarPubMed
McGurk, SR, Twamley, EW, Sitzer, DI, McHugo, GJ, Mueser, KT (2007). A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry 164, 1791–1802.CrossRefGoogle ScholarPubMed
Nuechterlein, KH, Green, MF, Kern, RS, Baade, LE, Barch, DM, Cohen, JD, Essock, S, Fenton, WS, Frese, FJ 3rd, Gold, JM, Goldberg, T, Heaton, RK, Keefe, RS, Kraemer, H, Mesholam-Gately, R, Seidman, LJ, Stover, E, Weinberger, DR, Young, AS, Zalcman, S, Marder, SR (2008). The MATRICS Consensus Cognitive Battery, Part 1: test selection, reliability, and validity. American Journal of Psychiatry 165, 203–213.CrossRefGoogle ScholarPubMed
Penn, DL, Corrigan, PW, Bentall, RP, Racenstein, J, Newman, L (1997). Social cognition in schizophrenia. Psychological Bulletin 121, 114–132.CrossRefGoogle ScholarPubMed
Reeder, C, Newton, E, Frangou, S, Wykes, T (2004). Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophrenia Bulletin 30, 87–100.CrossRefGoogle Scholar
Reeder, C, Smedley, N, Butt, K, Bogner, D, Wykes, T (2006). Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophrenia Bulletin 32 (Suppl. 1), S123–S131.CrossRefGoogle ScholarPubMed
Reitan, RM, Waltson, D (1985). The Halstead-Reitan Neuropsychological Test Battery. Neuropsychology Press: Tucson, AZ.Google Scholar
Salovey, P, Mayer, JD (1990). Emotional intelligence. Imagination, Cognition, and Personality 9, 185–221.CrossRefGoogle Scholar
Schooler, N, Weissman, M, Hogarty, G (1979). Social adjustment scale for schizophrenics. In Resource Material for Community Mental Health Program Evaluators (ed. Hargreaves, W. A., Attkisson, C. C. and Sorenson, J.), pp. 290–303. DHHS publication no. (ADM) 79328. United States Department of Health, Education, and Welfare; Rockville, MD.Google Scholar
Sergi, MJ, Green, MF, Widmark, C, Reist, C, Erhart, S, Braff, DL, Kee, KS, Marder, SR, Mintz, J (2007). Cognition and neurocognition: effects of Risperidone, Olanzapine, and Haloperidol. American Journal of Psychiatry 164, 1585–1592.CrossRefGoogle ScholarPubMed
Sergi, MJ, Rassovsky, Y, Nuechterlein, KH, Green, MF (2006). Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. American Journal of Psychiatry 163, 448–454.CrossRefGoogle ScholarPubMed
Singer, JD, Willet, JB (2003). Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford University Press: New York.CrossRefGoogle Scholar
Wechsler, D (1981). Wechsler Adult Intelligence Scale–Revised. Psychological Corp.: New York.Google Scholar
Wechsler, D (1987). Manual for the Wechsler Memory Scale–Revised. Psychological Corp.: San Antonio, TX.Google Scholar
Wykes, T, Newton, E, Landau, S, Rice, C, Thompson, N, Frangou, S (2007). Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research 94, 221–230.CrossRefGoogle ScholarPubMed